Facebook
X
LinkedIn
ForwardJPHC CE: Diagnosis and Management of Pediatric Allergic Rhinoconjunctivitis in the US
1.0 NAPNAP contact hour of which 0.5 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10.
Allergic rhinoconjunctivitis (AR/C) is a common pediatric condition. The physical, emotional, and social burden of AR/C in children highlights the need for accurate diagnosis with optimal treatment. This review provides practical information on the diagnosis and management of pediatric AR/C. Key features of the patient history and physical exam needed to diagnose seasonal and perennial AR/C are covered. Various AR/C treatment options are reviewed such as allergen avoidance, pharmacotherapies, and allergy immunotherapy (both subcutaneous injections and sublingual tablets) as well as their mode of action, side effects, and their role in guideline-recommended therapy. Practical information such as pollen calendars, management algorithms, and treatment product characteristics have also been included in this review.
J Pediatr Health Care. (2025) 39, 489-502.
IMPORTANT: You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: [email protected]
Copyright © 2024 by the National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved.
This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1.0 NAPNAP contact hour of which 0.5 contain pharmacology content (Rx).
Keywords: Allergy immunotherapy, allergic rhinitis, conjunctivitis, sublingual immunotherapy tablets
Target Audience
Pediatric-focused advanced practice registered nurses
Learning Objectives
1.Describe features of seasonal and perennial AR/C.
2.Describe key steps in determining a diagnosis of AR/C.
3.Describe the 3 main components of AR/C management.
4.List drug classes typically used in the treatment of AR/C.
5.Describe situations in which a referral to an allergy/immunology specialist may be required
Karen Rance, DNP, CPNP, Head of Medical Affairs, North America, ALK, Bedminster, NJ
Nancy Banasiak, DNP, PNP, APRN, Professor of nursing director, Yale School of Nursing, Orange, CT
Amanda Filippelli, MPH, MSN, APRN, PPCNP-BC, AE-C Nurse practitioner, Connecticut Children’s Medical Center, Hartford, CT
Sarah Heinonen, DNP, APRN, CPNP-AC/PC Nurse practitioner III, Children’s Hospital Los Angeles, Los Angeles, CA Medical
Disclosure:
K.Rance was an employee of ALK at the time of this work.
N.Banasiak has nothing to disclose.
A.Filippelli has nothing to disclose.
S.Heinonen has nothing to disclose.
Medical writing and editorial assistance were funded by ALK, Bedminster, New Jersey. The funder contributed to the writing of the report and the decision to submit the manuscript.
CONFLICTS OF INTEREST
No relevant conflicts of interest to disclose
Correspondence:
Karen Rance, DNP, CPNP
ALK
US Highway 135 Route 202/206
Bedminster, NJ 07921
e-mail: [email protected]
Available Credit
- 1.00 Contact hours